These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of the National Institute on Drug Abuse in the development of naltrexone. Ginzburg HM; Glass WJ J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with naltrexone in suburban opioid addicts. Tennant FS; Rawson RA; Cohen AJ; Mann A J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935 [TBL] [Abstract][Full Text] [Related]
7. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Mintzer IL; Eisenberg M; Terra M; MacVane C; Himmelstein DU; Woolhandler S Ann Fam Med; 2007; 5(2):146-50. PubMed ID: 17389539 [TBL] [Abstract][Full Text] [Related]
8. Naltrexone in addicted physicians and business executives. Washton AM; Gold MS; Pottash AC NIDA Res Monogr; 1984; 55():185-90. PubMed ID: 6443377 [TBL] [Abstract][Full Text] [Related]
9. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol]. Fontaine E; Godfroid IO; Guillaume R Encephale; 2001; 27(2):187-93. PubMed ID: 11407272 [TBL] [Abstract][Full Text] [Related]
10. [Naltrexone and prevention of opiate dependence relapse. An Italian experience]. Cibin M; Gentile N; Ferri M; Gallimberti L Minerva Psichiatr; 1989; 30(2):93-8. PubMed ID: 2779401 [TBL] [Abstract][Full Text] [Related]
12. Predictors of favorable outcome following naltrexone treatment. Greenstein RA; Evans BD; McLellan AT; O'Brien CP NIDA Res Monogr; 1983 Apr; 43():294-301. PubMed ID: 6410264 [No Abstract] [Full Text] [Related]
13. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients. Stella L; D'Ambra C; Mazzeo F; Capuano A; Del Franco F; Avolio A; Ambrosino F Life Sci; 2005 Oct; 77(21):2717-22. PubMed ID: 15979652 [TBL] [Abstract][Full Text] [Related]
14. Update of naltrexone treatment. O'Brien CP; Greenstein R; Woody GE NIDA Res Monogr; 1978; (19):315-20. PubMed ID: 218107 [TBL] [Abstract][Full Text] [Related]
15. Psychotherapy and naltrexone in opioid dependence. Resnick RB; Washton AM; Stone-Washton N NIDA Res Monogr; 1981 Feb; 34():109-15. PubMed ID: 6783917 [No Abstract] [Full Text] [Related]
16. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence. Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678 [TBL] [Abstract][Full Text] [Related]
17. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics. Verebey K NIDA Res Monogr; 1981; 28():147-58. PubMed ID: 6791001 [TBL] [Abstract][Full Text] [Related]
18. Naltrexone for opioid addiction. Med Lett Drugs Ther; 1985 Feb; 27(680):11-2. PubMed ID: 3969057 [No Abstract] [Full Text] [Related]